We used insurance claims to examine the prevalence and prescribing patterns of prescription opioids in a national cohort of individuals experiencing a treated heroin-related overdose between 2010 and 2017.
Reports and Articles from the Drug Policy Research Center
The RAND Drug Policy Research Center publishes current research in the following eight categories:
- Use, Predictors, and Consequences
- Policy, Law, and Regulation
- Markets and Supply
- Prevention and Brief Interventions
- Harm Reduction
- Data and Methods
Most Recent Publications on Drugs and Drug Policy
Prevalence and Predictors of Driving After Prescription Opioid Use in an Adult ED Sample July 31, 2020
Prescription opioid use and driving is a public health concern given the risks associated with drugged driving. We examined the prevalence and correlates of driving after taking prescription opioids among adults seeking emergency department treatment.
The Public Health Value of Opioid Litigation July 31, 2020
This article proceeds in three parts: discussions of the general goals and role of public health tort litigation, the demonstrated and potential value of opioid litigation to achieve public health goals, and a conclusion.
Systematic Review of the Emerging Literature on the Effectiveness of Naloxone Access Laws in the United States July 28, 2020
The existing literature on naloxone access laws in the United States supports beneficial effects for increased naloxone distribution, but provides inconclusive evidence for reduced fatal opioid overdose.
Telemedicine for treating Substance use disorder (SUD) use is growing steadily among treatment facilities; however, uptake is uneven and relatively low. As such, telemedicine may be an under-utilized tool to expand access to care for patients with SUD.